Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.
The aim of this study is to determine the prevalence of pneumococcal meningitis in the paediatric population in Spain four years after the marketing of Prevenar. Also secondary objectives are: 1) to determine the clinical characteristics and outcome of the disease; and 2) to determine serotypes and antibiotic resistance patterns.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Prevalence of Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00227214
|Alcalá de Henares, Spain|
|Barco de Valdeorras, Spain|
|Boadilla del Monte, Spain|
|Esplugues de Llobregat, Spain|
|La Coruña, Spain|
|Monforte de Lemos, Spain|
|San Lorenzo de El Escorial, Spain|
|San Sebastián, Spain|
|Study Director:||Pfizer CT.gov Call Center||Wyeth is now a wholly owned subsidiary of Pfizer|